Targeting Efflux Pumps to Overcome Antifungal Drug Resistance
Open accessThe DOI matches its Crossref record; 102 of the 102 references it cites were found in a registry or an index.
Abstract
Resistance to antifungal drugs is an increasingly significant clinical problem. The most common antifungal resistance encountered is efflux pump-mediated resistance of Candida species to azole drugs. One approach to overcome this resistance is to inhibit the pumps and chemosensitize resistant strains to azole drugs. Drug discovery targeting fungal efflux pumps could thus result in the development of azole-enhancing combination therapy. Heterologous expression of fungal efflux pumps in Saccharomyces cerevisiae provides a versatile system for screening for pump inhibitors. Fungal efflux pumps transport a range of xenobiotics including fluorescent compounds. This enables the use of fluorescence-based detection, as well as growth inhibition assays, in screens to discover compounds targeting efflux-mediated antifungal drug resistance. A variety of medium- and high-throughput screens have been used to identify a number of chemical entities that inhibit fungal efflux pumps.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“but that tolerance is not a function of either uptake or efflux rates, despite the well-known role of efflux in drug resistance [65][66][67][68][69] .”
From Antifungal tolerance is a subpopulation effect distinct from resistance and is associated with persistent candidemia (2018) · cites this paper as [66]
Citations
Cites
1 retracted
Maurya, I. K., Thota, C. K., Verma, S. D., Sharma, J., Rawal, M. K., Ravikumar, B., Sen, S., Chauhan, N., Lynn, A. M., Chauhan, V. S., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.467159 · Cited by 33
RetractedZhang, J.-H., Chung, T. D. Y., & Oldenburg, K. R. (1999) · SLAS Discovery · doi:10.1177/108705719900400206 · Cited by 6,847
Expression of Multidrug Resistance Gene in Human Cancers
Goldstein, L. J., Galski, H., Fojo, A., Willingham, M., Lai, S.-L., Gazdar, A., Pirker, R., Green, A., Crist, W., Brodeur, G. M., et al. (1989) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/81.2.116 · Cited by 1,290
The Antimicrobial Resistance Crisis: Causes, Consequences, and Management
Michael, C. A., Dominey-Howes, D., & Labbate, M. (2014) · Frontiers in Public Health · doi:10.3389/fpubh.2014.00145 · Cited by 974
Sanglard, D., Kuchler, K., Ischer, F., Pagani, J. L., Monod, M., & Bille, J. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.11.2378 · Cited by 815
Kathawala, R. J., Gupta, P., Ashby, C. R., & Chen, Z.-S. (2015) · Drug Resistance Updates · doi:10.1016/j.drup.2014.11.002 · Cited by 777
Crystal structures of a multidrug transporter reveal a functionally rotating mechanism
Murakami, S., Nakashima, R., Yamashita, E., Matsumoto, T., & Yamaguchi, A. (2006) · Nature · doi:10.1038/nature05076 · Cited by 773
White, T. C. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.7.1482 · Cited by 612
Efflux-Mediated Antifungal Drug Resistance
Cannon, R. D., Lamping, E., Holmes, A. R., Niimi, K., Baret, P. V., Keniya, M. V., Tanabe, K., Niimi, M., Goffeau, A., & Monk, B. C. (2009) · Clinical Microbiology Reviews · doi:10.1128/cmr.00051-08 · Cited by 608
Self-citationResistance to echinocandin-class antifungal drugs.
Perlin, D. S. (2007) · Drug Resistance Updates · doi:10.1016/j.drup.2007.04.002 · Cited by 512
Resistance Mechanisms in Clinical Isolates of Candida albicans
White, T. C., Holleman, S., Dy, F., Mirels, L. F., & Stevens, D. A. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.6.1704-1713.2002 · Cited by 461
Sanglard, D., Ischer, F., Monod, M., & Bille, J. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.10.2300 · Cited by 402
Structure of the Multidrug Transporter EmrD from Escherichia coli
Yin, Y., He, X., Szewczyk, P., Nguyen, T., & Chang, G. (2006) · Science · doi:10.1126/science.1125629 · Cited by 387
ATPase and Multidrug Transport Activities of the Overexpressed Yeast ABC Protein Yor1p
Decottignies, A., Grant, A. M., Nichols, J. W., de Wet, H., McIntosh, D. B., & Goffeau, A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.20.12612 · Cited by 382
Pfaller, M. A., Castanheira, M., Lockhart, S. R., Ahlquist, A. M., Messer, S. A., & Jones, R. N. (2012) · Journal of Clinical Microbiology · doi:10.1128/jcm.06112-11 · Cited by 377
Janbon, G., Ormerod, K. L., Paulet, D., Byrnes, E. J., Yadav, V., Chatterjee, G., Mullapudi, N., Hon, C.-C., Billmyre, R. B., Brunel, F., et al. (2014) · PLoS Genetics · doi:10.1371/journal.pgen.1004261 · Cited by 371
Structures of the multidrug exporter AcrB reveal a proximal multisite drug-binding pocket
Nakashima, R., Sakurai, K., Yamasaki, S., Nishino, K., & Yamaguchi, A. (2011) · Nature · doi:10.1038/nature10641 · Cited by 348
Sanglard, D., Ischer, F., Calabrese, D., Majcherczyk, P. A., & Bille, J. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.11.2753 · Cited by 337
Drug Export Pathway of Multidrug Exporter AcrB Revealed by DARPin Inhibitors
Sennhauser, G., Amstutz, P., Briand, C., Storchenegger, O., & Grütter, M. G. (2006) · PLoS Biology · doi:10.1371/journal.pbio.0050007 · Cited by 334
Echinocandin resistance: an emerging clinical problem?
Arendrup, M. C., & Perlin, D. S. (2014) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000111 · Cited by 299
Structural basis for the inhibition of bacterial multidrug exporters
Nakashima, R., Sakurai, K., Yamasaki, S., Hayashi, K., Nagata, C., Hoshino, K., Onodera, Y., Nishino, K., & Yamaguchi, A. (2013) · Nature · doi:10.1038/nature12300 · Cited by 298
Recent advances toward a molecular mechanism of efflux pump inhibition
Opperman, T. J., & Nguyen, S. T. (2015) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.00421 · Cited by 266
Zhang, L., Yan, K., Zhang, Y., Huang, R., Bian, J., Zheng, C., Sun, H., Chen, Z., Sun, N., An, R., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0609370104 · Cited by 248
Crystal Structure of the Multidrug Exporter MexB from Pseudomonas aeruginosa
Sennhauser, G., Bukowska, M. A., Briand, C., & Grütter, M. G. (2009) · Journal of Molecular Biology · doi:10.1016/j.jmb.2009.04.001 · Cited by 247
Mesa-Arango, A. C., Trevijano-Contador, N., Román, E., Sánchez-Fresneda, R., Casas, C., Herrero, E., Argüelles, J. C., Pla, J., Cuenca-Estrella, M., & Zaragoza, O. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03570-14 · Cited by 232
Yeast ATP-Binding Cassette Transporters Conferring Multidrug Resistance
Prasad, R., & Goffeau, A. (2012) · Annual Review of Microbiology · doi:10.1146/annurev-micro-092611-150111 · Cited by 221
Lamping, E., Monk, B. C., Niimi, K., Holmes, A. R., Tsao, S., Tanabe, K., Niimi, M., Uehara, Y., & Cannon, R. D. (2007) · Eukaryotic Cell · doi:10.1128/ec.00091-07 · Cited by 190
Self-citationEfflux Inhibition with Verapamil Potentiates Bedaquiline in Mycobacterium tuberculosis
Gupta, S., Cohen, K. A., Winglee, K., Maiga, M., Diarra, B., & Bishai, W. R. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01462-13 · Cited by 186
Nakamura, K., Niimi, M., Niimi, K., Holmes, A. R., Yates, J. E., Decottignies, A., Monk, B. C., Goffeau, A., & Cannon, R. D. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.12.3366-3374.2001 · Cited by 184
Self-citationWaltzing transporters and 'the dance macabre' between humans and bacteria
Lomovskaya, O., Zgurskaya, H. I., Totrov, M., & Watkins, W. J. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2200 · Cited by 183
Antifungals: Mechanism of Action and Drug Resistance
Prasad, R., Shah, A. H., & Rawal, M. K. (2016) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-319-25304-6_14 · Cited by 183
Fungal PDR transporters: Phylogeny, topology, motifs and function
Lamping, E., Baret, P. V., Holmes, A. R., Monk, B. C., Goffeau, A., & Cannon, R. D. (2010) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2009.10.007 · Cited by 162
Self-citationDrug:H+ antiporters in chemical stress response in yeast
Sá-Correia, I., dos Santos, S. C., Teixeira, M. C., Cabrito, T. R., & Mira, N. P. (2009) · Trends in Microbiology · doi:10.1016/j.tim.2008.09.007 · Cited by 161
Molecular Mechanisms of Primary Resistance to Flucytosine in Candida albicans
Hope, W. W., Tabernero, L., Denning, D. W., & Anderson, M. J. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.11.4377-4386.2004 · Cited by 160
Holmes, A. R., Lin, Y.-H., Niimi, K., Lamping, E., Keniya, M., Niimi, M., Tanabe, K., Monk, B. C., & Cannon, R. D. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00463-08 · Cited by 159
Self-citationAparna, V., Kesavan, D. K., Mohanalakshmi, N., Velmurugan, D., & Hopper, W. (2014) · PLoS ONE · doi:10.1371/journal.pone.0101840 · Cited by 152
Gottesman, M. M., & Pastan, I. H. (2015) · Journal of the National Cancer Institute · doi:10.1093/jnci/djv222 · Cited by 148
Modulation of human multidrug-resistance MDR-1 gene by natural curcuminoids
Limtrakul, P., Anuchapreeda, S., & Buddhasukh, D. (2004) · BMC Cancer · doi:10.1186/1471-2407-4-13 · Cited by 144
Functional Characterization of Candida albicans ABC Transporter Cdr1p
Shukla, S., Saini, P., Smriti, Jha, S., Ambudkar, S. V., & Prasad, R. (2003) · Eukaryotic Cell · doi:10.1128/ec.2.6.1361-1375.2003 · Cited by 135
Niimi, K., Maki, K., Ikeda, F., Holmes, A. R., Lamping, E., Niimi, M., Monk, B. C., & Cannon, R. D. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.4.1148-1155.2006 · Cited by 134
Self-citationDodgson, A. R., Dodgson, K. J., Pujol, C., Pfaller, M. A., & Soll, D. R. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.6.2223-2227.2004 · Cited by 133
Hiraga, K., Yamamoto, S., Fukuda, H., Hamanaka, N., & Oda, K. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.01.075 · Cited by 126
Tsao, S., Rahkhoodaee, F., & Raymond, M. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00926-08 · Cited by 126
Sharma, M., Manoharlal, R., Shukla, S., Puri, N., Prasad, T., Ambudkar, S. V., & Prasad, R. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01497-08 · Cited by 117
Sharma, M., & Prasad, R. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00344-11 · Cited by 116
MFS multidrug transporters in pathogenic fungi: do they have real clinical impact?
Costa, C., Dias, P. J., Sá-Correia, I., & Teixeira, M. C. (2014) · Frontiers in Physiology · doi:10.3389/fphys.2014.00197 · Cited by 115
Niimi, K., Harding, D. R. K., Parshot, R., King, A., Lun, D. J., Decottignies, A., Niimi, M., Lin, S., Cannon, R. D., Goffeau, A., et al. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.4.1256-1271.2004 · Cited by 114
Self-citationFlo11p, drug efflux pumps, and the extracellular matrix cooperate to form biofilm yeast colonies
Váchová, L., Šťovíček, V., Hlaváček, O., Chernyavskiy, O., S̆tĕpánek, L., Kubínová, L., & Palková, Z. (2011) · The Journal of Cell Biology · doi:10.1083/jcb.201103129 · Cited by 110
Microbial fermentation-derived inhibitors of efflux-pump-mediated drug resistance
Lee, M. D., Galazzo, J. L., Staley, A. L., Lee, J. C., Warren, M. S., Fuernkranz, H. A., Chamberland, S., Lomovskaya, O., & Miller, G. H. (2001) · Il Farmaco · doi:10.1016/s0014-827x(01)01002-3 · Cited by 108
Evolution of gene families: the multidrug resistance transporter genes in five related yeast species
Gbelska, Y., Krijger, J.-J., & Breunig, K. D. (2006) · FEMS Yeast Research · doi:10.1111/j.1567-1364.2006.00058.x · Cited by 107
Ivnitski-Steele, I., Holmes, A. R., Lamping, E., Monk, B. C., Cannon, R. D., & Sklar, L. A. (2009) · Analytical Biochemistry · doi:10.1016/j.ab.2009.07.001 · Cited by 106
Self-citationHolmes, A. R., Keniya, M. V., Ivnitski-Steele, I., Monk, B. C., Lamping, E., Sklar, L. A., & Cannon, R. D. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05706-11 · Cited by 106
Self-citationSafa, A. (2004) · Current Medicinal Chemistry-Anti-Cancer Agents · doi:10.2174/1568011043482142 · Cited by 105
Schuetzer‐Muehlbauer, M., Willinger, B., Egner, R., Ecker, G., & Kuchler, K. (2003) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(03)00213-9 · Cited by 103
Chemosensitization as a Means to Augment Commercial Antifungal Agents
Campbell, B. C., Chan, K. L., & Jong Heon, K. I. M. (2012) · Frontiers in Microbiology · doi:10.3389/fmicb.2012.00079 · Cited by 97
Jensen, R. H., Astvad, K. M. T., Silva, L. V., Sanglard, D., Jørgensen, R., Nielsen, K. F., Mathiasen, E. G., Doroudian, G., Perlin, D. S., & Arendrup, M. C. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv140 · Cited by 95
Liu, X., Tee, H.-W., & Go, M. (2007) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2007.10.006 · Cited by 95
[39] Plasma membrane ATPase from the yeast Saccharomyces cerevisiae
Goffeau, A., & Dufour, J. (1988) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/0076-6879(88)57101-x · Cited by 92
MDR1 -Mediated Drug Resistance in Candida dubliniensis
Wirsching, S., Moran, G. P., Sullivan, D. J., Coleman, D. C., & Morschhäuser, J. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.12.3416-3421.2001 · Cited by 91
Schmid, D., Ecker, G. F., Kopp, S., Hitzler, M., & Chiba, P. (1999) · Biochemical Pharmacology · doi:10.1016/s0006-2952(99)00229-4 · Cited by 80
Tanabe, K., Lamping, E., Adachi, K., Takano, Y., Kawabata, K., Shizuri, Y., Niimi, M., & Uehara, Y. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.10.110 · Cited by 75
Sandberg, M., Määttänen, A., Peltonen, J. P. K., Vuorela, P. M., & Fallarero, A. (2008) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2008.04.022 · Cited by 73
Young, S. M., Bologa, C., Prossnitz, E. R., Oprea, T. I., Sklar, L. A., & Edwards, B. S. (2005) · SLAS Discovery · doi:10.1177/1087057105274532 · Cited by 72
Self-citationDornetshuber, R., Heffeter, P., Sulyok, M., Schumacher, R., Chiba, P., Kopp, S., Koellensperger, G., Micksche, M., Lemmens‐Gruber, R., & Berger, W. (2009) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200800384 · Cited by 70
Phenothiazines as potent modulators of yeast multidrug resistance
Kołaczkowski, M., Michalak, K., & Motohashi, N. (2003) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(03)00214-0 · Cited by 69
Flow Cytometry: Impact on Early Drug Discovery
Edwards, B. S., & Sklar, L. A. (2015) · SLAS DISCOVERY · doi:10.1177/1087057115578273 · Cited by 66
Self-citationReversal of Fluconazole Resistance by Sulfated Sterols from the Marine Sponge Topsentia sp.
DiGirolamo, J. A., Li, X., Jacob, M. R., Clark, A. M., & Ferreira, D. (2009) · Journal of Natural Products · doi:10.1021/np900177m · Cited by 65
Suzuki, K., Saito, K., Tsujimura, S., Nakayamada, S., Yamaoka, K., Sawamukai, N., Iwata, S., Nawata, M., Nakano, K., & Tanaka, Y. (2010) · The Journal of Rheumatology · doi:10.3899/jrheum.090048 · Cited by 63
Hertogh, B. D., Carvajal, E., Talla, E., Dujon, B., Baret, P. V., & Goffeau, A. (2002) · Functional & Integrative Genomics · doi:10.1007/s10142-002-0060-8 · Cited by 62
Mechanisms of fluconazole resistance in Candida albicans isolates from Japanese AIDS patients
Maebashi, K., Niimi, M., Kudoh, M., Fischer, F. J., Makimura, K., Niimi, K., Piper, R. J., Uchida, K., Arisawa, M., Cannon, R. D., et al. (2001) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/47.5.527 · Cited by 59
Self-citationLaFleur, M. D., Lucumi, E., Napper, A. D., Diamond, S. L., & Lewis, K. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq530 · Cited by 59
Keniya, M. V., Fleischer, E., Klinger, A., Cannon, R. D., & Monk, B. C. (2015) · PLOS ONE · doi:10.1371/journal.pone.0126350 · Cited by 58
Self-citationIbuprofen reverts antifungal resistance on Candida albicans showing overexpression of CDR genes
Ricardo, E., Costa-de-Oliveira, S., Silva Dias, A., Guerra, J., Rodrigues, A. G., & Pina-Vaz, C. (2009) · FEMS Yeast Research · doi:10.1111/j.1567-1364.2009.00504.x · Cited by 56
Mechanisms of azole resistance in Candida albicans clinical isolates from Shanghai, China
Liu, J.-Y., Shi, C., Wang, Y., Li, W.-J., Zhao, Y., & Xiang, M.-J. (2015) · Research in Microbiology · doi:10.1016/j.resmic.2015.02.009 · Cited by 54
Niimi, K., Harding, D. R. K., Holmes, A. R., Lamping, E., Niimi, M., Tyndall, J. D. A., Cannon, R. D., & Monk, B. C. (2012) · Molecular Microbiology · doi:10.1111/j.1365-2958.2012.08140.x · Cited by 49
Self-citationMilbemycins: More than Efflux Inhibitors for Fungal Pathogens
Silva, L. V., Sanguinetti, M., Vandeputte, P., Torelli, R., Rochat, B., & Sanglard, D. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02040-12 · Cited by 49
The Efflux Pump Inhibitor Timcodar Improves the Potency of Antimycobacterial Agents
Grossman, T. H., Shoen, C. M., Jones, S. M., Jones, P. L., Cynamon, M. H., & Locher, C. P. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.04271-14 · Cited by 46
Li, X., Jacob, M. R., Ding, Y., Agarwal, A. K., Smillie, T. J., Khan, S. I., Nagle, D. G., Ferreira, D., & Clark, A. M. (2006) · Journal of Natural Products · doi:10.1021/np050396y · Cited by 44
Mane, A., Vidhate, P., Kusro, C., Waman, V., Saxena, V., Kulkarni‐Kale, U., & Risbud, A. (2016) · Mycoses · doi:10.1111/myc.12439 · Cited by 41
Shah, A. H., Rawal, M. K., Dhamgaye, S., Komath, S. S., Saxena, A. K., & Prasad, R. (2015) · Scientific Reports · doi:10.1038/srep11211 · Cited by 39
Potentiation of Azole Antifungals by 2-Adamantanamine
LaFleur, M. D., Sun, L., Lister, I., Keating, J., Nantel, A., Long, L., Ghannoum, M., North, J., Lee, R. E., Coleman, K., et al. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00294-13 · Cited by 35
Hayama, K., Ishibashi, H., Ishijima, S. A., Niimi, K., Tansho, S., Ono, Y., Monk, B. C., Holmes, A. R., Harding, D. R. K., Cannon, R. D., et al. (2012) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2011.02490.x · Cited by 34
Self-citationSingh, P., Kaur, J. P., Yadav, B., & Komath, S. S. (2009) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2009.04.026 · Cited by 34
Yamamoto, S., Hiraga, K., Abiko, A., Hamanaka, N., & Oda, K. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.03.009 · Cited by 33
Candida Efflux ATPases and Antiporters in Clinical Drug Resistance
Prasad, R., Rawal, M. K., & Shah, A. H. (2016) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-319-25304-6_15 · Cited by 30
Detection of inhibitors of Candida albicans Cdr transporters using a diS-C3(3) fluorescence
Szczepaniak, J., Łukaszewicz, M., & Krasowska, A. (2015) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.00176 · Cited by 29
Kołaczkowski, M., Kołaczkowska, A., Motohashi, N., & Michalak, K. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00956-08 · Cited by 27
Charlier, C., El Sissy, C., Bachelier-Bassi, S., Scemla, A., Quesne, G., Sitterlé, E., Legendre, C., Lortholary, O., & Bougnoux, M.-E. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02265-15 · Cited by 26
Learning the ABC of oral fungal drug resistance
Cannon, R. D., & Holmes, A. R. (2015) · Molecular Oral Microbiology · doi:10.1111/omi.12109 · Cited by 24
Self-citationCerulenin Analogues as Inhibitors of Efflux Pumps in Drug‐resistant Candida albicans
Diwischek, F., Morschhäuser, J., & Holzgrabe, U. (2009) · Archiv der Pharmazie · doi:10.1002/ardp.200800160 · Cited by 24
Tanabe, K., Lamping, E., Nagi, M., Okawada, A., Holmes, A. R., Miyazaki, Y., Cannon, R. D., Monk, B. C., & Niimi, M. (2011) · Molecular Microbiology · doi:10.1111/j.1365-2958.2011.07820.x · Cited by 24
Self-citationŁącka, I., Konieczny, M. T., Buɬakowska, A., Kodedová, M., Gášková, D., Maurya, I. K., Prasad, R., & Milewski, S. (2015) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.00783 · Cited by 22
Antifungal action of the oxathiolone‐fused chalcone derivative
Łącka, I., Konieczny, M. T., Buɬakowska, A., Rzymowski, T., & Milewski, S. (2010) · Mycoses · doi:10.1111/j.1439-0507.2010.01936.x · Cited by 21
Monitoring the kinetics and performance of yeast membrane ABC transporters by diS-C3(3) fluorescence
Gášková, D., Čadek, R., Chaloupka, R., Vaçata, V., Gebel, J., & Sigler, K. (2002) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(02)00013-4 · Cited by 21
A high throughput flow cytometric assay platform targeting transporter inhibition
Tegos, G. P., Evangelisti, A. M., Strouse, J. J., Ursu, O., Bologa, C., & Sklar, L. A. (2014) · Drug Discovery Today Technologies · doi:10.1016/j.ddtec.2014.03.010 · Cited by 19
Self-citationYoungsaye, W., Vincent, B., Hartland, C. L., Morgan, B. J., Buhrlage, S. J., Johnston, S. E., Bittker, J. A., MacPherson, L. J., Dandapani, S., Palmer, M. A. J., et al. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.06.105 · Cited by 18
Hiraga, K., WANIGASEKERA, A., Hisanori, S. U. G. I., Hamanaka, N., & Oda, K. (2001) · Bioscience Biotechnology and Biochemistry · doi:10.1271/bbb.65.1589 · Cited by 16
Youngsaye, W., Hartland, C. L., Morgan, B. J., Ting, A., Nag, P. P., Vincent, B., Mosher, C. A., Bittker, J. A., Dandapani, S., Palmer, M. A. J., et al. (2013) · Beilstein Journal of Organic Chemistry · doi:10.3762/bjoc.9.171 · Cited by 15
Maki, N., & Dey, S. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.04.008 · Cited by 14
WANIGASEKERA, A., Hiraga, K., Hamanaka, N., & Oda, K. (2001) · Bioscience Biotechnology and Biochemistry · doi:10.1271/bbb.65.2353 · Cited by 4
Diwischek, F., Morschhäuser, J., & Holzgrabe, U. (2009) · ChemInform · doi:10.1002/chin.200927192 · Cited by 3
Hartland, C. L., Youngsaye, W., Morgan, B. J., Ting, A., Nag, P. P., Buhrlage, S. J., Johnston, S. E., Bittker, J. A., Vincent, B., Whitesell, L. J., et al. (2011) · Cited by 2
Research works printed but not linked: 2
- Cannon R SklarLA LindsleyC. Phenotypic HTS multiplex for anti-fungal efflux pump inhibitors. PubChem Bioassay Screening Summary; PubChem AID 485335 (2010). http://pubchem.ncbi.nlm.nih.gov/assay/assay.cgi?aid=485335.
- Hartland CL , YoungsayeW, DockendorffCet al. Identification of small molecules that selectively inhibit fluconazole-resistant Candida albicans in the presence of fluconazole but not in its absence – Probe 3. In : Probe Reports from the NIH Molecular Libraries Program. Bethesda, MD (2010).
Cited by
Rosenberg, A., Ene, I. V., Bibi, M., Zakin, S., Segal, E. S., Ziv, N., Dahan, A. M., Colombo, A. L., Bennett, R. J., & Berman, J. (2018) · Nature Communications · doi:10.1038/s41467-018-04926-x · Cited by 270
Antifungal Drug Resistance: An Emergent Health Threat
Vitiello, A., Ferrara, F., Boccellino, M., Ponzo, A., Cimmino, C., Comberiati, E., Zovi, A., Clemente, S., & Sabbatucci, M. (2023) · Biomedicines · doi:10.3390/biomedicines11041063 · Cited by 228
Spengler, G., Kincses, A., Gajdács, M., & Amaral, L. (2017) · Molecules · doi:10.3390/molecules22030468 · Cited by 189
Dermatophyte Resistance to Antifungal Drugs: Mechanisms and Prospectus
Martinez-Rossi, N. M., Bitencourt, T. A., Peres, N. T. A., Lang, E. A. S., Gomes, E. V., Quaresemin, N. R., Martins, M. P., Lopes, L., & Rossi, A. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01108 · Cited by 183
The Role of Eukaryotic and Prokaryotic ABC Transporter Family in Failure of Chemotherapy
El-Awady, R., Saleh, E., Hashim, A., Soliman, N., Dallah, A., Elrasheed, A., & Elakraa, G. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00535 · Cited by 162
“…cells by membrane transporters is the most predominant and mutual mechanism of resistance among all organisms (Tillotson and Tillotson, 2010) These membrane transporters are proteins that belong to a superfamily of genes called the ABC (Holmes et al., 2016; Ye et al., 2016; Zhang et al., 2016).”
Background
Metadata
- Authors
- Holmes, A. R., Cardno, T. S., Strouse, J. J., Ivnitski-Steele, I., Keniya, M. V., Lackovic, K., Monk, B. C., Sklar, L. A., & Cannon, R. D.
- Affiliations
- University of Otago (NZ)
- The University of Melbourne (AU)
- University of New Mexico (US)
- New Mexico Center for Molecular Discovery, University of New Mexico, Albuquerque, New Mexico, USA
- Corresponding author
- Cannon, Richard D
- Venue
- Future Medicinal Chemistry
- Publisher
- Informa UK Limited
- Published
- 2016-07-27
- Volume
- 8
- Issue
- 12
- Pages
- 1485-1501
- ISSN
- 1756-8919 (ISSN-L)
- 1756-8927
- PMC
- PMC5827819
- OpenAlex
- W2478702959
- Cited by
- 156
- References
- 102
- Citations by year
- 2026: 20 · 2025: 24 · 2024: 18 · 2023: 24 · 2022: 16 · 2021: 14 · 2020: 18 · 2019: 10 · 2018: 6 · 2017: 6
- FWCI
- 1.13
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Future Medicinal Chemistry (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (R01-DE016855-01; R03-MH087406-1A1)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
- Keywords
- antifungal resistance, efflux pumps, Candida, chemosensitization, combination therapy, heterologous expression in Saccharomyces cerevisiae, fluorescence-based screening, high-throughput screening, drug discovery
- MeSH terms
- Antifungal Agents, Azoles, Fungi, Humans, Microbial Sensitivity Tests, Mycoses, Drug Resistance, Fungal, Membrane Transport Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.